These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| AWARE, INC. | ||
| (Exact Name of Registrant as Specified in Its Charter) | ||
| Massachusetts | 04-2911026 | ||||
| (State or Other Jurisdiction of | (I.R.S. Employer Identification No.) | ||||
| Incorporation or Organization) | |||||
| 40 Middlesex Turnpike, Bedford, Massachusetts 01730 |
| (Address of Principal Executive Offices) |
| (Zip Code) |
|
(781) 276-4000
|
||
|
(Registrant’s Telephone Number, Including Area Code)
|
||
| Title of Each Class | Name of Each Exchange on Which Registered | |||
| Common Stock, par value $.01 per share | The Nasdaq Global Market | |||
|
PART I
|
||||
|
Item 1.
|
Business
|
3
|
||
|
Item 1A.
|
Risk Factors
|
12
|
||
|
Item 1B.
|
Unresolved Staff Comments
|
17
|
||
|
Item 2.
|
Properties
|
18
|
||
|
Item 3.
|
Legal Proceedings
|
18
|
||
|
Item 4.
|
Mine Safety Disclosures
|
18
|
||
|
PART II
|
||||
|
Item 5.
|
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
|
19
|
||
|
Item 6.
|
Selected Financial Data
|
21
|
||
|
Item 7.
|
Management’s Discussion and Analysis of Financial Condition and Results
of Operations
|
22
|
||
|
Item 7A.
|
Quantitative and Qualitative Disclosures About Market Risk
|
34
|
||
|
Item 8.
|
Financial Statements and Supplementary Data
|
35
|
||
|
Item 9.
|
Changes in and Disagreements with Accountants on Accounting and Financial
Disclosure
|
58
|
||
|
Item 9A.
|
Controls and Procedures
|
58
|
||
|
Item 9B.
|
Other Information
|
58
|
||
|
PART III
|
||||
|
Item 10.
|
Directors, Executive Officers and Corporate Governance
|
59
|
||
|
Item 11.
|
Executive Compensation
|
59
|
||
|
Item 12.
|
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
|
59
|
||
|
Item 13.
|
Certain Relationships and Related Transactions, and Director Independence
|
59
|
||
|
Item 14.
|
Principal Accountant Fees and Services
|
59
|
||
|
PART IV
|
||||
|
Item 15.
|
Exhibits and Financial Statement Schedule
|
60
|
||
|
Signatures
|
62
|
|||
| 2 |
| 3 |
|
i)
|
Technology suppliers
– Within this category, there are suppliers that provide software and hardware technologies that enable biometrics systems.
|
| 4 |
|
ii)
|
System integrators
– This category of suppliers includes companies that provide system integration services. System integrators purchase hardware and software from biometrics technology vendors, such as those listed immediately above. They then incorporate those components into customized biometrics systems that they build for their end-user customers.
|
|
iii)
|
Fully integrated solutions vendors
– This category of suppliers includes companies that are fully integrated providers of biometric systems. Such companies combine their in-house hardware and software technologies with their systems integration services to deliver customized biometrics systems to their end-user customers. While these vendors may purchase some components from third parties, we believe such component purchases represent a minor portion of the total systems they deliver.
|
|
|
●
|
Hardware, scanner, and integrated solutions companies, such as: i) DigitalPersona, Inc.; ii) Bioscrypt, Inc., a division of Safran Morpho; iii) Suprema, Inc.; iv) 3M/Cogent; and v) Eyelock, Inc.
|
|
|
●
|
Software platform companies, such as: i) M2Sys; ii) BIO-key International, Inc.; iii) Imprivata, Inc; and iv) Facebanx, a subsidiary of OhHi, Ltd.
|
|
|
●
|
Access control companies, such as: i) Honeywell International, Inc.; ii) HID Global Corporation; iii) Tyco International Ltd.; iv) Lenel Systems International Inc.; v) Stanley Security Limited; vi) IrisGuard, Inc.; and vii) Aurora Biometrics, Inc.; and
|
|
|
●
|
Smart phone companies, such as Apple, Inc. through its acquisition of AuthenTec, Inc.
|
| 5 |
|
|
i)
|
Software Development Kits. S
oftware development kits or (“SDKs”) consist of multiple software libraries, sample applications that show customers how to use the libraries, and documentation. Customers use our SDKs to design their own applications using our libraries. We consider these products to be commercial off-the-shelf (“COTS”) products because they are ready-made products not customized by us for any particular customer. Our SDK products and the functions they perform are:
|
|
|
●
|
Products for hardware abstraction, autocapture, and quality assurance:
|
|
|
a)
|
FastCapture with LiveScan API;
|
|
|
b)
|
PreFace
TM
with Camera API;
|
|
|
c)
|
IrisCheck
TM
with IrisCam API;
|
|
|
d)
|
SequenceCheck
TM
; and
|
|
|
e)
|
Quality Check
TM
.
|
|
|
●
|
Products for biometric data formatting, validation and reading
according to ANSI/NIST, ISO/IEC, INCITS, ICAO, FIPS 201, and other U.S. and international standards:
|
|
|
a)
|
NISTPack;
|
|
|
b)
|
ICAOPack;
|
|
|
c)
|
PIVPack
TM
; and
|
|
|
d)
|
M1Pack.
|
|
|
●
|
Products for compression and decompression of fingerprint, facial, and iris images:
|
|
|
a)
|
Aware WSQ; and
|
|
|
b)
|
Aware JPEG2000.
|
|
|
●
|
Products for biometric authentication:
|
|
|
a)
|
AwareXM
TM
|
|
|
●
|
Products for scanning and printing of fingerprint cards:
|
|
|
a)
|
AccuScan
TM
; and
|
|
|
b)
|
AccuPrint
TM
.
|
|
|
●
|
Products for mobile devices:
|
|
|
a)
|
NISTPack Mobile
|
|
|
b)
|
ICAOPack Mobile
|
|
|
c)
|
PIVPack
TM
Mobile; and
|
|
|
d)
|
AwareXM
TM
Mobile.
|
|
|
●
|
Bundles of products for specific applications:
|
|
|
a)
|
CaptureSuite
TM
-
for capture of either live scan or card scan fingerprint images;
|
|
|
b)
|
PIVSuite
TM
– for registration, identity proofing, and ID card personalization, issuance, and reading; and
|
|
|
c)
|
ICAOSuite
TM
- for biometric and biographic enrollment, e-passport personalization and reading, and fingerprint verification.
|
|
|
ii)
|
Software components
. Our software component products each include a user interface and one or more software libraries that perform a discrete set of functions. Software components allow customers to develop biometric applications more quickly than using our SDKs. Our set of products in this category is called BioComponents
TM
. BioComponents comprises modular, independent, self-contained software components that can operate either independently or in concert with each other performing a specific biometric task. Each biometric capture component has its own configurable user interface, and performs all tasks and workflows required for capture, hardware abstraction, and quality assurance.
|
| 6 |
|
|
iii)
|
Biometric applications
. Our products in this category combine a user interface with multiple Aware software libraries into more complete biometrics applications. Our application products and the functions they perform are:
|
|
|
●
|
Universal Registration Client (“URC”)
TM
.
URC is a configurable Windows-based application that performs a variety of biometric data capture, analysis, matching, formatting, and hardware abstraction functions.
|
|
|
●
|
URC Mobile
. URC Mobile is a software application for performing biometric enrollment, identification, and screening on mobile biometric devices, such as those used by military personnel in the field.
|
|
|
●
|
FormScannerSE and FormScannerMB
. These are two independent applications for scanning and processing of inked fingerprint cards.
|
|
|
●
|
FormScannerSWFT
. This product is a version of FormScannerSE that is preconfigured for use in compliance with the “Secure Web Fingerprint Transmission” program of the U.S. Department of Defense.
|
|
|
●
|
Forensic Workbench
. Forensic Workbench is a software application for the categorization, processing, and standards-compliant formatting of biometric images and demographic data.
|
|
|
●
|
WebEnroll
. WebEnroll provides a reference application with applets for browser-based enrollment of biographic data, fingerprints, and facial images.
|
|
|
iv)
|
Server-based solutions
. Our product in this category is called Biometrics Services Platform or BioSP
TM
. This product is used to build and deploy server-based biometric data processing and workflow solutions. BioSP supports the collection of biometric images from a distributed network, and the subsequent aggregation, analysis, processing and integration of this data into larger systems.
|
|
|
i)
|
Systems integrator services – this category of services includes engineering services we provide to our systems integrator customers for assistance with biometrics systems they are developing for their customers. Such services may include software customization, integration, installation, or engineering problem solving.
|
|
|
ii)
|
Direct government services - this category of services arises when government customers contract directly with us for services products involving the development of complete biometrics systems, software development, and engineering problem solving.
|
| 7 |
|
|
i)
|
Systems integrator channel – we sell to systems integrators that incorporate our software products into biometrics systems that are delivered primarily to government end users.
|
|
|
ii)
|
OEM channel – we sell to hardware and software solution providers that incorporate our software products into their products.
|
|
|
iii)
|
Direct channel – we also sell directly to government, and, to a lesser degree, to commercial customers.
|
|
|
i)
|
Product line expansion
– We intend to introduce new products that will allow us to sell more software into biometrics systems and projects. Our preference is to develop new products internally by adding resources to our existing engineering staff. To the extent we are unable to develop critical new technologies internally, we may purchase or license such technologies from third parties. Alternatively, we may also acquire biometrics companies provided we believe the acquisition cost is reasonable relative to the estimated future revenue and profits the acquired company may produce.
|
|
|
ii)
|
Geographic expansion
– We believe that there are growth opportunities for biometrics projects outside of the United States. We intend to pursue foreign markets through additions to our sales staff, as well as through the use of third party sales agents.
|
|
|
iii)
|
Grow services revenue
– We believe that services represent a significant portion of the total biometrics market. We further believe we can grow our services revenue by offering customers high quality engineering services that are delivered responsively at attractive prices. Our services business may benefit from past successes on services projects with other customers.
|
| 8 |
|
|
iv)
|
Commercial market expansion
– Historically our revenue has been primarily derived from government biometrics markets. Given the nature of the product solutions required in that market, we have been able to forge a profitable business model. It has been less obvious to us how we replicate that profitable model in commercial markets. As commercial markets grow and product solutions become more complex, we intend to identify opportunities where we can participate profitability.
|
| 9 |
| 10 |
| 11 |
|
|
●
|
the lack or reduction of government funding and the political, budgetary and purchasing constraints of government customers who purchase products and services directly or indirectly from us;
|
|
|
●
|
the terms of customer contracts that affect the timing of revenue recognition;
|
|
|
●
|
the size and timing of our receipt of customer orders;
|
|
|
●
|
significant fluctuations in demand for our products and services;
|
|
|
●
|
the loss of a key customer or one of its key customers;
|
|
|
●
|
new competitors, or the introduction of enhanced solutions from new or existing competitors;
|
|
|
●
|
competitive pressures on selling prices;
|
|
|
●
|
cancellations, delays or contract amendments by government customers;
|
|
|
●
|
higher than expected costs, asset write-offs, and other one-time financial charges; and
|
|
|
●
|
general economic trends and other factors
|
|
|
●
|
changes in fiscal policies or decreases in available government funding,
|
|
|
●
|
changes in government funding priorities;
|
|
|
●
|
changes in government programs or applicable requirements;
|
|
|
●
|
the adoption of new laws or regulations or changes to existing laws or regulations;
|
|
|
●
|
changes in political or social attitudes with respect to security and defense issues;
|
|
|
●
|
changes in audit policies and procedures of government entities;
|
|
|
●
|
potential delays or changes in the government appropriations process; and
|
|
|
●
|
delays in the payment of our invoices by government payment offices.
|
| 12 |
|
|
●
|
a reduction in sales efforts by our partners;
|
|
|
●
|
the failure of our partners to win government awards in which our products are used;
|
|
|
●
|
a reduction in technical capabilities or financial viability of our partners;
|
|
|
●
|
a misalignment of interest between us and them;
|
|
|
●
|
the termination of our relationship with a major systems integrator or OEM; or
|
|
|
●
|
any adverse effect on a partner’s business related to competition, pricing and other factors.
|
|
|
●
|
the cost, performance and reliability of our products and services and the products and services offered by our competitors;
|
|
|
●
|
the continued growth in demand for biometrics solutions within the government and law enforcement markets as well as the development and growth of demand for biometric solutions in markets outside of government and law enforcement;
|
|
|
●
|
customers’ perceptions regarding the benefits of biometrics solutions;
|
|
|
●
|
public perceptions regarding the intrusiveness of these solutions and the manner in which organizations use the biometric information collected;
|
|
|
●
|
public perceptions regarding the confidentiality of private information;
|
|
|
●
|
proposed or enacted legislation related to privacy of information;
|
|
|
●
|
customers’ satisfaction with biometrics solutions; and
|
|
|
●
|
marketing efforts and publicity regarding biometrics solutions.
|
|
|
●
|
Diversified technology providers that offer integrated biometrics solutions to governments, law enforcement agencies and other organizations. This group of competitors includes companies such as Safran Morpho, a division of the Safran Group Company; 3M Cogent, and NEC Corporation.
|
| 13 |
|
|
●
|
Component providers that offer biometrics software and hardware components for fingerprint, facial, and iris biometric identification. This group of competitors includes companies such as Cognitec Systems GmbH; Neurotechnology; Iritech, Inc.; Iris ID Systems, Inc.; Innovatrics s.r.o.; WCC Group B.V.; Daon, Inc.; and M2Sys Technology (“M2Sys”).
|
| 14 |
| 15 |
|
|
●
|
reduced demand for our products;
|
|
|
●
|
increased risk of order cancellations or delays;
|
|
|
●
|
increased pressure on the prices for our products;
|
|
|
●
|
greater difficulty in collecting accounts receivable; and
|
|
|
●
|
risks to our liquidity, including the possibility that we might not have access to our cash when needed.
|
|
|
●
|
quarterly variations in operating results;
|
|
|
●
|
announcements of technological innovations or new products by us or our competitors,
|
|
|
●
|
changes in customer relationships, such as the loss of a key customer;
|
|
|
●
|
recruitment or departure of key personnel;
|
|
|
●
|
corporate actions we may initiate, such as acquisitions, stock sales or repurchases, dividend declarations, or corporate reorganizations; and
|
|
|
●
|
other events or factors.
|
| 16 |
| 17 |
| 18 |
|
First
|
Second
|
Third
|
Fourth
|
|||||||||||||
|
Quarter
|
Quarter
|
Quarter
|
Quarter
|
|||||||||||||
|
2013
|
||||||||||||||||
|
High
|
$ | 6.25 | $ | 5.65 | $ | 5.64 | $ | 6.14 | ||||||||
|
Low
|
4.58 | 4.50 | 4.80 | 5.06 | ||||||||||||
|
2012
|
||||||||||||||||
|
High
|
$ | 4.68 | $ | 7.50 | $ | 6.88 | $ | 6.90 | ||||||||
|
Low
|
2.30 | 3.34 | 5.31 | 5.05 | ||||||||||||
| 19 |
|
Value of Investment ($)
|
||||||||||||||||||||||||
|
12/31/08
|
12/31/09
|
12/31/10
|
12/31/11
|
12/31/12
|
12/31/13
|
|||||||||||||||||||
|
Aware, Inc.
|
$ | 100.00 | $ | 149.73 | $ | 151.87 | $ | 160.43 | $ | 467.26 | $ | 520.97 | ||||||||||||
|
Nasdaq Composite Index
|
100.00 | 144.88 | 170.58 | 171.30 | 199.99 | 283.39 | ||||||||||||||||||
|
RDG Technology Composite
|
100.00 | 160.94 | 181.64 | 181.83 | 208.18 | 274.77 | ||||||||||||||||||
| 20 |
|
Year ended December 31,
|
2013
|
2012
|
2011
|
2010
|
2009
|
|||||||||||||||
|
(in thousands, except per share data)
|
||||||||||||||||||||
|
Statements of Comprehensive Income Data
|
||||||||||||||||||||
|
Revenue
|
$ | 19,357 | $ | 17,304 | $ | 16,199 | $ | 12,975 | $ | 15,856 | ||||||||||
|
Operating income (loss) before
patent related income
|
4,538 | 5,043 | 3,500 | (360 | ) | (3,834 | ) | |||||||||||||
|
Gain on sale of patent assets
|
- | 86,394 | - | - | - | |||||||||||||||
|
Gain on sale of assets
|
- | - | - | - | 6,230 | |||||||||||||||
|
Income from continuing operations, net of income taxes
|
3,752 | 72,383 | 3,581 | 154 | 2,629 | |||||||||||||||
|
Income (loss) from discontinued operations, net of income taxes
|
(1,156 | ) | (76 | ) | (1,014 | ) | 26 | (1,647 | ) | |||||||||||
|
Net income
|
2,596 | 72,307 | 2,567 | 180 | 982 | |||||||||||||||
|
Net income per share – basic
|
$ | 0.12 | $ | 3.32 | $ | 0.12 | $ | 0.01 | $ | 0.05 | ||||||||||
|
Net income per share – diluted
|
$ | 0.11 | $ | 3.28 | $ | 0.12 | $ | 0.01 | $ | 0.05 | ||||||||||
|
Balance Sheet Data
|
||||||||||||||||||||
|
Cash and cash equivalents
|
$ | 72,660 | $ | 71,074 | $ | 46,577 | $ | 39,949 | $ | 39,669 | ||||||||||
|
Working capital
|
75,760 | 73,358 | 48,069 | 43,818 | 42,209 | |||||||||||||||
|
Total assets
|
89,329 | 85,854 | 57,851 | 53,400 | 51,454 | |||||||||||||||
|
Total liabilities
|
4,179 | 3,958 | 3,276 | 3,517 | 3,094 | |||||||||||||||
|
Total stockholders’ equity
|
85,150 | 81,896 | 54,575 | 49,883 | 48,360 | |||||||||||||||
| 21 |
|
Year ended December 31,
|
||||||||||||
|
Revenue:
|
2013
|
2012
|
2011
|
|||||||||
|
Software licenses
|
43 | % | 55 | % | 48 | % | ||||||
|
Software maintenance
|
20 | 18 | 16 | |||||||||
|
Services
|
16 | 15 | 23 | |||||||||
|
Hardware sales
|
16 | - | - | |||||||||
|
Royalties
|
5 | 12 | 13 | |||||||||
|
Total revenue
|
100 | 100 | 100 | |||||||||
|
Costs and expenses:
|
||||||||||||
|
Cost of hardware sales
|
12 | - | - | |||||||||
|
Cost of services
|
8 | 9 | 9 | |||||||||
|
Research and development
|
21 | 20 | 20 | |||||||||
|
Selling and marketing
|
18 | 20 | 18 | |||||||||
|
General and administrative
|
18 | 22 | 31 | |||||||||
|
Total costs and expenses
|
77 | 71 | 78 | |||||||||
|
Operating income before patent related income
|
23 | 29 | 22 | |||||||||
|
Gain on sale of patent assets
|
- | 499 | - | |||||||||
|
Income from patent arrangement
|
4 | 7 | - | |||||||||
|
Operating income after patent related income
|
27 | 535 | 22 | |||||||||
|
Other income
|
- | - | - | |||||||||
|
Interest income
|
2 | 1 | - | |||||||||
|
Income from continuing operations before income taxes
|
29 | 536 | 22 | |||||||||
|
Provision for income taxes
|
10 | 118 | - | |||||||||
|
Income from continuing operations
|
19 | 418 | 22 | |||||||||
|
Loss from discontinued operations, net of income taxes
|
(6 | ) | - | (6 | ) | |||||||
|
Net income
|
13 | % | 418 | % | 16 | % | ||||||
| 22 |
|
Years ended December 31,
|
||||||||||||
|
2013
|
2012
|
2011
|
||||||||||
|
Income from continuing operations
|
$ | 3,752 | $ | 72,383 | $ | 3,581 | ||||||
|
Loss from discontinued operations, net of income taxes
|
(1,156 | ) | (76 | ) | (1,014 | ) | ||||||
|
Net income
|
$ | 2,596 | $ | 72,307 | $ | 2,567 | ||||||
| 23 |
| 24 |
| 25 |
|
Years ended December 31,
|
||||||||||||
|
2013
|
2012
|
2011
|
||||||||||
|
Research and development expense
|
$ | 4,085 | $ | 3,489 | $ | 3,203 | ||||||
|
Cost of services
|
1,503 | 1,542 | 1,518 | |||||||||
|
Total engineering costs
|
$ | 5,588 | $ | 5,031 | $ | 4,721 | ||||||
| 26 |
| ● |
On April 26, 2012, we entered into an agreement with an unaffiliated third party to sell a portion of our patent portfolio pertaining to wireless technology for $75.0 million. The proceeds from the sale were reduced by $3.8 million of transaction costs, which consisted primarily of fees from the law firm that assisted us in the sale. The transaction closed on June 21, 2012 and resulted in a gain of $71.2 million.
|
| ● |
On August 22, 2012, we entered into an agreement with an unaffiliated third party to sell a portion of our patent portfolio pertaining to digital subscriber line (“DSL”) technology for $16.0 million. The proceeds from the sale were reduced by $0.8 million of transaction costs, which also consisted primarily of fees from the law firm that assisted us in the sale. The transaction closed on September 21, 2012 and resulted in a gain of $15.2 million.
|
| 27 |
|
|
●
|
a tax benefit of $95,000 related to the 2012 research tax credit. This credit was extended retroactively back to January 1, 2012, by the American Taxpayer Relief Act of 2012, which was enacted on January 2, 2013; and
|
|
|
●
|
a tax benefit of $148,000 related to a reduction in the estimate of the 2012 tax expense recorded in our 2012 financial statements.
|
| 28 |
|
Years ended December 31,
|
||||||||||||
|
2013
|
2012
|
2011
|
||||||||||
|
Revenue
|
$ | 3,216 | $ | 5,431 | $ | 8,387 | ||||||
|
Expenses
|
5,120 | 5,558 | 9,401 | |||||||||
|
Loss before income taxes
|
(1,904 | ) | (127 | ) | (1,014 | ) | ||||||
|
Income tax benefit
|
(748 | ) | (51 | ) | - | |||||||
|
Loss from discontinued operations
|
($ | 1,156 | ) | ($ | 76 | ) | ($ | 1,014 | ) | |||
|
|
●
|
Cash provided by on-going operations of $6.7 million was the result of: i) operating income before patent related income of $5.0 million; ii) interest income and other income of $0.3 million; iii) adjustments for non-cash items related to depreciation and stock-based compensation of $0.5 million and $0.3 million, respectively; and iv) changes in working capital components that increased cash by $0.6 million.
|
|
|
●
|
Cash provided by on-going operations of $6.7 million was reduced by $22.0 million of income tax items that were incurred as a result of our patent sales in 2012. The $22.0 million of income tax items comprises: i) $7.6 million of tax payments; and ii) $14.4 million of tax expense that is reduced by a tax benefit from excess stock-based compensation that must be presented as cash flows from financing activities under generally accepted accounting principles as opposed to an item that benefits cash flows from operating activities.
|
| 29 |
| 30 |
| 31 |
|
Payments Due By Period
|
||||||||||||||||||||
|
Contractual Obligations
|
Total
|
Less than
1 year
|
1-3 years
|
3-5 years
|
More than
5 years
|
|||||||||||||||
|
Purchase orders
|
$ | 57 | $ | 57 | $ | - | $ | - | $ | - | ||||||||||
|
Total
|
$ | 57 | $ | 57 | $ | - | $ | - | $ | - | ||||||||||
| o |
When software licenses and maintenance contracts are sold together, we recognize software license revenue upon delivery, provided we have vendor specific objective evidence (“VSOE”) for the fair value of the maintenance contract fee, and we recognize the fair value of maintenance contract revenue ratably over the related contract period.
|
|
o
|
When engineering services and software licenses are sold together, the total fee is generally recognized by applying contract accounting. We have adopted the percentage-of-completion method of contract accounting, and we primarily use an input method (i.e., labor hours) to determine our completion percentage.
|
|
o
|
When we sell services, software licenses and maintenance together, revenue is recognized as follows: i) maintenance revenue is separated from the other two elements and is recognized ratably over the related contract period; provided we have VSOE for the fair value of the maintenance element; and ii) the total fee from the software license and engineering service elements is recognized by applying the contract accounting method described in the previous paragraph.
|
|
o
|
We have a multiple element arrangement with one customer that involves the delivery of hardware, maintenance, and services. We determined that these elements qualified as separate units of accounting because they have value to the customer on a standalone basis. Accordingly, we recognize hardware revenue upon delivery and acceptance by the customer, maintenance revenue ratably over the related contract period, and service revenue as services are delivered.
|
| 32 |
| 33 |
|
1.
|
Cash and cash equivalents.
As of December 31, 2013, our cash and cash equivalents of $72.7 million were primarily invested in money market funds. The money market funds were invested in high quality, short term financial instruments. Due to the nature, short duration, and professional management of these funds, we do not expect that a general increase in interest rates would result in any material loss.
|
|
2.
|
Investments.
As of December 31, 2013, our investments of $2.8 million were invested in high yield bonds with five corporate debt issuers, which mature in 2015 through 2018. While we are exposed to default risk, the high current yield of these bonds largely mitigates interest rate risk. Therefore, due to the high current yield and the two to five year life of these instruments, we do not believe that a general increase in interest rates would result in any material loss.
|
| 34 |
| 35 |
| 36 |
|
December 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
ASSETS
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$ | 72,660 | $ | 71,074 | ||||
|
Accounts receivable (less allowance for doubtful
accounts of $20 at December 31, 2013 and 2012)
|
4,582 | 3,457 | ||||||
|
Receivable from patent arrangement
|
- | 1,121 | ||||||
|
Inventories
|
1,601 | - | ||||||
|
Deferred tax assets
|
383 | 817 | ||||||
|
Prepaid expenses and other current assets
|
695 | 528 | ||||||
|
Total current assets
|
79,921 | 76,997 | ||||||
|
Property and equipment, net
|
5,582 | 5,904 | ||||||
|
Investments
|
2,754 | 2,010 | ||||||
|
Long term deferred tax assets
|
762 | 943 | ||||||
|
Other assets
|
310 | - | ||||||
|
Total assets
|
$ | 89,329 | $ | 85,854 | ||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable
|
$ | 1,516 | $ | 328 | ||||
|
Accrued expenses
|
108 | 148 | ||||||
|
Accrued compensation
|
571 | 817 | ||||||
|
Accrued professional fees
|
118 | 142 | ||||||
|
Deferred revenue
|
1,848 | 2,204 | ||||||
|
Total current liabilities
|
4,161 | 3,639 | ||||||
|
Long-term deferred revenue
|
18 | 319 | ||||||
|
Commitments and contingent liabilities (Note 9)
|
||||||||
|
Stockholders’ equity:
|
||||||||
|
Preferred stock, $1.00 par value; 1,000,000 shares authorized,
none outstanding
|
- | - | ||||||
|
Common stock, $.01 par value; shares authorized,
70,000,000 in 2013 and 2012; issued
and outstanding 22,574,251 in 2013 and 22,509,518 in 2012
|
226 | 225 | ||||||
|
Additional paid-in capital
|
101,293 | 100,561 | ||||||
|
Accumulated other comprehensive loss
|
(125 | ) | (50 | ) | ||||
|
Accumulated deficit
|
(16,244 | ) | (18,840 | ) | ||||
|
Total stockholders’ equity
|
85,150 | 81,896 | ||||||
|
Total liabilities and stockholders’ equity
|
$ | 89,329 | $ | 85,854 | ||||
| 37 |
|
Years ended December 31,
|
||||||||||||
|
2013
|
2012
|
2011
|
||||||||||
|
Revenue:
|
||||||||||||
|
Software licenses
|
$ | 8,241 | $ | 9,525 | $ | 7,801 | ||||||
|
Software maintenance
|
3,866 | 3,038 | 2,590 | |||||||||
|
Services
|
3,148 | 2,571 | 3,662 | |||||||||
|
Hardware sales
|
3,182 | - | - | |||||||||
|
Royalties
|
920 | 2,170 | 2,146 | |||||||||
|
Total revenue
|
19,357 | 17,304 | 16,199 | |||||||||
|
Costs and expenses:
|
||||||||||||
|
Cost of hardware sales
|
2,365 | - | - | |||||||||
|
Cost of services
|
1,503 | 1,542 | 1,518 | |||||||||
|
Research and development
|
4,085 | 3,489 | 3,203 | |||||||||
|
Selling and marketing
|
3,344 | 3,370 | 2,973 | |||||||||
|
General and administrative
|
3,522 | 3,860 | 5,005 | |||||||||
|
Total costs and expenses
|
14,819 | 12,261 | 12,699 | |||||||||
|
Operating income before patent related income
|
4,538 | 5,043 | 3,500 | |||||||||
|
Gain on sale of patent assets
|
- | 86,394 | - | |||||||||
|
Income from patent arrangement
|
780 | 1,121 | - | |||||||||
|
Operating income after patent related income
|
5,318 | 92,558 | 3,500 | |||||||||
|
Other income
|
23 | 85 | - | |||||||||
|
Interest income
|
328 | 227 | 83 | |||||||||
|
Income from continuing operations before income taxes
|
5,669 | 92,870 | 3,583 | |||||||||
|
Provision for income taxes
|
1,917 | 20,487 | 2 | |||||||||
|
Income from continuing operations
|
3,752 | 72,383 | 3,581 | |||||||||
|
Loss from discontinued operations, net of income taxes
|
(1,156 | ) | (76 | ) | (1,014 | ) | ||||||
|
Net income
|
$ | 2,596 | $ | 72,307 | $ | 2,567 | ||||||
|
Basic net income per share:
|
||||||||||||
|
Basic net income per share from continuing operations
|
$ | 0.17 | $ | 3.32 | $ | 0.17 | ||||||
|
Basic net loss per share from discontinued operations
|
(0.05 | ) | (0.00 | ) | (0.05 | ) | ||||||
|
Basic net income per share
|
$ | 0.12 | $ | 3.32 | $ | 0.12 | ||||||
|
Diluted net income per share:
|
||||||||||||
|
Diluted net income per share from continuing operations
|
$ | 0.16 | $ | 3.28 | $ | 0.17 | ||||||
|
Diluted net loss per share from discontinued operations
|
(0.05 | ) | (0.00 | ) | (0.05 | ) | ||||||
|
Diluted net income per share
|
$ | 0.11 | $ | 3.28 | $ | 0.12 | ||||||
|
Weighted-average shares - basic
|
22,543 | 21,814 | 20,534 | |||||||||
|
Weighted-average shares - diluted
|
22,641 | 22,071 | 20,735 | |||||||||
|
Comprehensive income:
|
||||||||||||
|
Net income
|
$ | 2,596 | $ | 72,307 | $ | 2,567 | ||||||
|
Other comprehensive income (net of tax):
|
||||||||||||
|
Unrealized losses on available for sale securities
|
(75 | ) | (30 | ) | (20 | ) | ||||||
|
Comprehensive income
|
$ | 2,521 | $ | 72,277 | $ | 2,547 | ||||||
| 38 |
|
Years ended December 31,
|
||||||||||||
|
2013
|
2012
|
2011
|
||||||||||
|
Cash flows from operating activities:
|
||||||||||||
|
Net income
|
$ | 2,596 | $ | 72,307 | $ | 2,567 | ||||||
|
Adjustments to reconcile net income to net cash
provided by (used in) operating activities:
|
||||||||||||
|
Depreciation and amortization
|
458 | 453 | 475 | |||||||||
|
Stock-based compensation
|
662 | 321 | 1,277 | |||||||||
|
Gain on sale of patent assets
|
- | (86,394 | ) | - | ||||||||
|
Amortization of premium (discount) on investments
|
15 | (18 | ) | (9 | ) | |||||||
|
Gain on sale of investments
|
(23 | ) | (85 | ) | - | |||||||
|
Deferred tax benefit on other comprehensive income
|
81 | - | - | |||||||||
|
Loss on disposal of property and equipment
|
28 | - | - | |||||||||
|
Provision for doubtful accounts
|
- | 4 | - | |||||||||
|
Increase (decrease) from changes in assets and liabilities:
|
||||||||||||
|
Accounts receivable
|
(1,125 | ) | 85 | 1,422 | ||||||||
|
Receivable from patent arrangement
|
1,121 | (1,121 | ) | - | ||||||||
|
Inventories
|
(1,601 | ) | 547 | 1,316 | ||||||||
|
Prepaid expenses and other current assets
|
(167 | ) | (315 | ) | 22 | |||||||
|
Deferred tax assets
|
563 | (1,760 | ) | - | ||||||||
|
Accounts payable
|
1,188 | (71 | ) | (166 | ) | |||||||
|
Accrued expenses, compensation and professional
|
(310 | ) | 9 | (590 | ) | |||||||
|
Deferred revenue
|
(657 | ) | 744 | 515 | ||||||||
|
Net cash provided by (used in) operating activities
|
2,829 | (15,294 | ) | 6,829 | ||||||||
|
Cash flows from investing activities:
|
||||||||||||
|
Purchases of property and equipment
|
(160 | ) | (116 | ) | (331 | ) | ||||||
|
Proceeds from sale of property and equipment
|
24 | - | - | |||||||||
|
Purchases of investments
|
(2,008 | ) | (2,065 | ) | (737 | ) | ||||||
|
Sales of investments
|
1,117 | 855 | - | |||||||||
|
Proceeds from sale of patent assets, net
|
- | 86,394 | - | |||||||||
|
Purchase of other assets
|
(338 | ) | - | - | ||||||||
|
Net cash provided by (used in) investing activities
|
(1,365 | ) | 85,068 | (1,068 | ) | |||||||
|
Cash flows from financing activities:
|
||||||||||||
|
Proceeds from issuance of common stock
|
65 | 6,526 | 1,826 | |||||||||
|
Payment of dividends
|
- | (66,024 | ) | - | ||||||||
|
Excess tax benefits from stock-based compensation
|
128 | 14,395 | - | |||||||||
|
Payments made for taxes of employees who surrendered
shares related to unrestricted stock
|
(71 | ) | (174 | ) | (224 | ) | ||||||
|
Repurchase of common stock
|
- | - | (735 | ) | ||||||||
|
Net cash provided by (used in) financing activities
|
122 | (45,277 | ) | 867 | ||||||||
|
Increase in cash and cash equivalents
|
1,586 | 24,497 | 6,628 | |||||||||
|
Cash and cash equivalents, beginning of year
|
71,074 | 46,577 | 39,949 | |||||||||
|
Cash and cash equivalents, end of year
|
$ | 72,660 | $ | 71,074 | $ | 46,577 | ||||||
|
Supplemental disclosure:
|
||||||||||||
|
Cash paid for income taxes
|
$ | 542 | $ | 7,954 | $ | 2 | ||||||
| 39 |
|
Additional
|
Accumulated
Other
|
Total
|
||||||||||||||||||||||
|
Common Stock
|
Paid-In
|
Comprehensive
|
(Accumulated
|
Stockholders’
|
||||||||||||||||||||
|
Shares
|
Amount
|
Capital
|
Loss
|
Deficit)
|
Equity
|
|||||||||||||||||||
|
Balance at December 31, 2010
|
20,042 | $ | 200 | $ | 77,373 | $ | - | ($ | 27,690 | ) | $ | 49,883 | ||||||||||||
|
Exercise of common stock options
|
596 | 6 | 1,804 | 1,810 | ||||||||||||||||||||
|
Issuance of unrestricted stock
|
300 | 3 | (3 | ) | - | |||||||||||||||||||
|
Shares surrendered by employees to
pay taxes related to unrestricted stock
|
(70 | ) | (1 | ) | (223 | ) | (224 | ) | ||||||||||||||||
|
Repurchase of common stock
|
(250 | ) | (2 | ) | (733 | ) | (735 | ) | ||||||||||||||||
|
Issuance of common stock under
employee stock purchase plan
|
5 | - | 17 | 17 | ||||||||||||||||||||
|
Stock-based compensation expense
|
- | - | 1,277 | 1,277 | ||||||||||||||||||||
|
Accumulated other comprehensive loss:
|
||||||||||||||||||||||||
|
Unrealized loss on securities
|
(20 | ) | (20 | ) | ||||||||||||||||||||
|
Net income
|
2,567 | 2,567 | ||||||||||||||||||||||
|
Balance at December 31, 2011
|
20,623 | 206 | 79,512 | (20 | ) | (25,123 | ) | 54,575 | ||||||||||||||||
|
Exercise of common stock options
|
1,764 | 18 | 6,481 | 6,499 | ||||||||||||||||||||
|
Issuance of unrestricted stock
|
151 | 1 | (1 | ) | - | |||||||||||||||||||
|
Shares surrendered by employees to
pay taxes related to unrestricted stock
|
(33 | ) | - | (174 | ) | (174 | ) | |||||||||||||||||
|
Issuance of common stock under
employee stock purchase plan
|
5 | - | 27 | 27 | ||||||||||||||||||||
|
Stock-based compensation expense
|
- | - | 321 | 321 | ||||||||||||||||||||
|
Tax benefits from stock-based awards
|
14,395 | 14,395 | ||||||||||||||||||||||
|
Dividend payment
|
(66,024 | ) | (66,024 | ) | ||||||||||||||||||||
|
Accumulated other comprehensive loss:
|
||||||||||||||||||||||||
|
Unrealized loss on securities
|
(30 | ) | (30 | ) | ||||||||||||||||||||
|
Net income
|
72,307 | 72,307 | ||||||||||||||||||||||
|
Balance at December 31, 2012
|
22,510 | 225 | 100,561 | (50 | ) | (18,840 | ) | 81,896 | ||||||||||||||||
|
Exercise of common stock options
|
6 | - | 26 | 26 | ||||||||||||||||||||
|
Issuance of unrestricted stock
|
65 | 1 | (1 | ) | - | |||||||||||||||||||
|
Shares surrendered by employees to
pay taxes related to unrestricted stock
|
(14 | ) | - | (71 | ) | (71 | ) | |||||||||||||||||
|
Issuance of common stock under
employee stock purchase plan
|
7 | - | 40 | 40 | ||||||||||||||||||||
|
Stock-based compensation expense
|
- | - | 662 | 662 | ||||||||||||||||||||
|
Tax benefits from stock-based awards
|
128 | 128 | ||||||||||||||||||||||
|
Deferred tax asset write-off
|
(52 | ) | (52 | ) | ||||||||||||||||||||
|
Accumulated other comprehensive loss:
|
||||||||||||||||||||||||
|
Unrealized loss on securities
|
(156 | ) | (156 | ) | ||||||||||||||||||||
|
Deferred tax benefit on unrealized losses
|
81 | 81 | ||||||||||||||||||||||
|
Net income
|
2,596 | 2,596 | ||||||||||||||||||||||
|
Balance at December 31, 2013
|
22,574 | $ | 226 | $ | 101,293 | ($ | 125 | ) | ($ | 16,244 | ) | $ | 85,150 | |||||||||||
| 40 |
|
1.
|
NATURE OF BUSINESS
|
|
2.
|
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
|
|
Fair Value Measurement at December 31, 2013 Using:
|
||||||||||||
|
Quoted Prices in
Active Markets for Identical Assets |
Significant Other
Observable Inputs |
Significant
Unobservable Inputs |
||||||||||
|
(Level 1)
|
(Level 2)
|
(Level 3)
|
||||||||||
|
Corporate debt securities
|
$ | 2,754 | $ | - | $ | - | ||||||
|
Money market funds (included in cash and cash equivalents)
|
68,556 | |||||||||||
|
Total
|
$ | 71,310 | $ | - | $ | - | ||||||
| 41 |
|
Fair Value Measurement at December 31, 2012 Using:
|
||||||||||||
|
Quoted Prices in
Active Markets for
Identical Assets
|
Significant Other
Observable Inputs |
Significant
Unobservable Inputs |
||||||||||
|
(Level 1)
|
(Level 2)
|
(Level 3)
|
||||||||||
|
Corporate debt securities
|
$ | 2,010 | $ | - | $ | - | ||||||
|
Money market funds (included in cash and cash equivalents)
|
67,050 | |||||||||||
|
Total
|
$ | 69,060 | $ | - | $ | - | ||||||
|
Building
|
30 years
|
|
|
Building improvements
|
5 to 20 years
|
|
|
Furniture and fixtures
|
5 years
|
|
|
Computer, office & manufacturing equipment
|
3 years
|
|
|
Purchased software
|
3 years
|
| 42 |
| 43 |
|
|
●
|
Software licenses and software maintenance
. When software licenses and software maintenance contracts are sold together, we recognize software license revenue upon delivery, provided we have vendor specific objective evidence (“VSOE”) for the fair value of the maintenance contract fee, and we recognize the fair value of maintenance contract revenue ratably over the related contract period.
|
|
|
●
|
Software licenses and services.
When software licenses and engineering services are sold together, the total fee is generally recognized by applying contract accounting. We have adopted the percentage-of-completion method of contract accounting, and we generally use an input method (i.e., labor hours) to determine our completion percentage. The software license portion of the arrangement is classified as software license revenue and the engineering services portion is classified as services revenue.
|
|
|
●
|
Software licenses, software maintenance and services.
When we sell software licenses, software maintenance and services together, revenue is recognized as follows: i) software maintenance revenue is separated from the other two elements and is recognized ratably over the related software maintenance contract period; provided we have VSOE for the fair value of the maintenance element; and ii) the total fee from the software license and engineering service elements is recognized by applying the contract accounting method described in the previous paragraph.
|
|
|
●
|
Hardware sales, software maintenance, and services.
We have a multiple element arrangement with one customer that involves the delivery of hardware, maintenance, and services. We determined that these elements qualified as separate units of accounting because they have value to the customer on a standalone basis. We recognize revenue from this arrangement as follows: i) hardware revenue is recognized upon delivery and acceptance of the equipment by the customer; ii) maintenance revenue is recognized ratably over the related contract period; and iii) service revenue is recognized as services are delivered.
|
| 44 |
| 45 |
|
3.
|
PATENT RELATED INCOME
|
|
4.
|
DISCONTINUED OPERATIONS
|
|
Years ended December 31,
|
||||||||||||
|
2013
|
2012
|
2011
|
||||||||||
|
Revenue
|
$ | 3,216 | $ | 5,431 | $ | 8,387 | ||||||
|
Expenses
|
5,120 | 5,558 | 9,401 | |||||||||
|
Loss before income taxes
|
(1,904 | ) | (127 | ) | (1,014 | ) | ||||||
|
Income tax benefit
|
(748 | ) | (51 | ) | - | |||||||
|
Loss from discontinued operations
|
($ | 1,156 | ) | ($ | 76 | ) | ($ | 1,014 | ) | |||
| 46 |
|
Customer
Contract Termination Costs |
Severance
and Employee- Related Costs |
Other
Costs |
Total
|
|||||||||||||
|
Year ended December 31, 2013
|
||||||||||||||||
|
Balance at January 1, 2013
|
$ | - | $ | - | $ | - | $ | - | ||||||||
|
Amount charged to expense
|
2,553 | 311 | 48 | 2,912 | ||||||||||||
|
Deferred revenue offset
|
1,179 | - | - | 1,179 | ||||||||||||
|
Payments/write-offs
|
(3,732 | ) | (221 | ) | (48 | ) | (4,001 | ) | ||||||||
|
Balance at December 31, 2013
|
$ | - | $ | 90 | $ | - | $ | 90 | ||||||||
|
Year ended December 31, 2012
|
||||||||||||||||
|
Balance at January 1, 2012
|
$ | - | $ | - | $ | - | $ | - | ||||||||
|
Amount charged to expense
|
- | 282 | - | 282 | ||||||||||||
|
Payments
|
- | (282 | ) | - | (282 | ) | ||||||||||
|
Balance at December 31, 2012
|
$ | - | $ | - | $ | - | $ | - | ||||||||
|
5.
|
INVENTORIES
|
|
2013
|
2012
|
||||||||
|
Raw materials
|
$ | 1,584 | $ | - | |||||
|
Finished goods
|
17 | - | |||||||
|
Total
|
$ | 1,601 | $ | - | |||||
|
6.
|
PROPERTY AND EQUIPMENT
|
|
2013
|
2012
|
|||||||
|
Land
|
$ | 1,056 | $ | 1,080 | ||||
|
Building and improvements
|
9,060 | 9,060 | ||||||
|
Computer equipment
|
557 | 605 | ||||||
|
Purchased software
|
88 | 131 | ||||||
|
Furniture and fixtures
|
778 | 779 | ||||||
|
Office equipment
|
191 | 181 | ||||||
|
Total
|
11,730 | 11,836 | ||||||
|
Less accumulated depreciation and amortization
|
(6,148 | ) | (5,932 | ) | ||||
|
Property and equipment, net
|
$ | 5,582 | $ | 5,904 | ||||
| 47 |
|
Year ended December 31,
|
|||||||||||||
|
2013
|
2012
|
2011
|
|||||||||||
|
Current:
|
|||||||||||||
|
Federal
|
$ | 1,000 | $ | 20,654 | $ | - | |||||||
|
State
|
273 | 1,594 | 2 | ||||||||||
| 1,273 | 22,248 | 2 | |||||||||||
|
Deferred:
|
|||||||||||||
|
Federal
|
471 | (1,354 | ) | - | |||||||||
|
State
|
173 | (407 | ) | - | |||||||||
| 644 | (1,761 | ) | - | ||||||||||
|
Total provision for income taxes
|
$ | 1,917 | $ | 20,487 | $ | 2 | |||||||
|
Year ended December 31,
|
||||||||||||
|
2013
|
2012
|
2011
|
||||||||||
|
Federal statutory rate
|
34 | % | 35 | % | 34 | % | ||||||
|
State rate, net of federal benefit
|
5 | 5 | 6 | |||||||||
|
Tax credits
|
(2 | ) | - | (9 | ) | |||||||
|
Permanent adjustments
|
(1 | ) | - | - | ||||||||
|
Change in valuation allowance
|
- | (18 | ) | (50 | ) | |||||||
|
Non-qualified option cancellations and forfeitures
|
- | - | 11 | |||||||||
|
Nondeductible compensation expense
|
- | - | (1 | ) | ||||||||
|
Prior year adjustment
|
(2 | ) | - | (2 | ) | |||||||
|
Expiring NOLs and tax credits
|
- | - | 10 | |||||||||
|
Other
|
- | - | 1 | |||||||||
|
Effective tax rate
|
34 | % | 22 | % | 0 | % | ||||||
|
|
●
|
a tax benefit of $95,000 related to the 2012 research tax credit. This credit was extended retroactively back to January 1, 2012, by the American Taxpayer Relief Act of 2012, which was enacted on January 2, 2013; and
|
|
|
●
|
a tax benefit of $148,000 related to a reduction in the estimate of the 2012 tax expense recorded in our 2012 financial statements.
|
| 48 |
|
|
As of December 31, 2013 and 2012, we had deferred tax assets for which we had recorded no valuation allowance. The principal components of deferred tax assets were as follows at December 31 (in thousands):
|
|
2013
|
2012
|
|||||||
|
Capitalized research and development costs
|
$ | 364 | $ | 817 | ||||
|
Research and development and other tax credit carryforwards
|
- | 27 | ||||||
|
Other
|
781 | 916 | ||||||
|
Total
|
1,145 | 1,760 | ||||||
|
Less valuation allowance
|
(- | ) | (- | ) | ||||
|
Deferred tax assets, net
|
$ | 1,145 | $ | 1,760 | ||||
|
Uncertain tax positions at December 31, 2011
|
$ | - | |||
|
Increase due to positions taken in prior periods
|
2,945 | ||||
|
Uncertain tax positions at December 31, 2012
|
$ | 2,945 | |||
|
Increase due to positions taken in prior periods
|
- | ||||
|
Uncertain tax positions at December 31, 2013
|
$ | 2,945 | |||
| 49 |
|
Years ended December 31,
|
||||||||||||
|
2013
|
2012
|
2011
|
||||||||||
|
Cost of services
|
$ | 34 | $ | 16 | $ | 29 | ||||||
|
Research and development
|
81 | 51 | 110 | |||||||||
|
Selling and marketing
|
14 | 126 | 108 | |||||||||
|
General and administrative
|
533 | 83 | 859 | |||||||||
|
Loss from discontinued operations
|
- | 45 | 171 | |||||||||
|
Stock-based compensation expense
|
$ | 662 | $ | 321 | $ | 1,277 | ||||||
|
Year Ended
December 31,
2013 |
Year Ended
December 31, 2012 |
Year Ended
December 31,
2011 |
|||||
|
Expected term (1)
|
n/a
|
5 years
|
n/a
|
||||
|
Expected volatility factor (2)
|
n/a
|
58-63%
|
n/a
|
||||
|
Risk-free interest rate (3)
|
n/a
|
0.92%
|
n/a
|
||||
|
Expected annual dividend yield
|
n/a
|
n/a
|
n/a
|
| 50 |
| 51 |
|
2013
|
2012
|
2011
|
||||||||||||||||||||||
|
Shares
|
Weighted
Average Exercise Price |
Shares
|
Weighted
Average Exercise Price |
Shares
|
Weighted
Average
Exercise
Price
|
|||||||||||||||||||
|
Outstanding at beginning of year
|
1,063,025 | $ | 5.63 | 2,835,952 | $ | 4.42 | 5,082,891 | $ | 4.30 | |||||||||||||||
|
Granted
|
- | - | 50,000 | 4.60 | - | - | ||||||||||||||||||
|
Exercised
|
(6,163 | ) | 4.27 | (1,779,616 | ) | 3.71 | (632,685 | ) | 3.02 | |||||||||||||||
|
Forfeited or cancelled
|
(51,873 | ) | 4.83 | (43,311 | ) | 4.33 | (1,614,254 | ) | 4.59 | |||||||||||||||
|
Outstanding at end of year
|
1,004,989 | $ | 5.68 | 1,063,025 | $ | 5.63 | 2,835,952 | $ | 4.42 | |||||||||||||||
|
Exercisable at year end
|
986,237 | $ | 5.70 | 1,027,525 | $ | 5.66 | 2,772,109 | $ | 4.44 | |||||||||||||||
|
Options Outstanding
|
Options Exercisable
|
|||||||||||||||||||
|
Exercise Price
Range
|
Number
|
Weighted
Average
Exercise
Price
|
Weighted Average
Remaining
Contractual
Term (in years)
|
Number
|
Weighted
Average
Exercise
Price
|
|||||||||||||||
|
$0 to $2
|
188 | $ | 1.95 | 0.08 | 188 | $ | 1.95 | |||||||||||||
|
$2 to $3
|
42,813 | 2.77 | 2.67 | 42,813 | 2.77 | |||||||||||||||
|
$3 to $4
|
53,000 | 3.45 | 3.63 | 44,666 | 3.52 | |||||||||||||||
|
$4 to $5
|
58,150 | 4.64 | 3.93 | 58,150 | 4.64 | |||||||||||||||
|
$5 to $6
|
29,000 | 5.07 | 3.14 | 29,000 | 5.07 | |||||||||||||||
|
$6 to $7
|
821,838 | 6.07 | 0.75 | 811,420 | 6.07 | |||||||||||||||
| 1,004,989 | $ | 5.68 | 1.24 | 986,237 | $ | 5.70 | ||||||||||||||
| 52 |
|
9.
|
COMMITMENTS AND CONTINGENT LIABILITIES
|
| 53 |
|
Year ended December 31,
|
||||||||||||
|
2013
|
2012
|
2011
|
||||||||||
|
United States
|
$ | 13,909 | $ | 12,158 | $ | 12,276 | ||||||
|
Rest of world
|
5,448 | 5,146 | 3,923 | |||||||||
| $ | 19,357 | $ | 17,304 | $ | 16,199 | |||||||
|
Year ended December 31,
|
||||||||||||
|
2013
|
2012
|
2011
|
||||||||||
|
Customer A
|
21 | % | 5 | % | 10 | % | ||||||
|
11.
|
EMPLOYEE BENEFIT PLAN
|
|
12.
|
NET INCOME PER SHARE
|
|
Year ended December 31,
|
||||||||||||
|
2013
|
2012
|
2011
|
||||||||||
|
Net income:
|
||||||||||||
|
Income from continuing operations
|
$ | 3,752 | $ | 72,383 | $ | 3,581 | ||||||
|
Loss from discontinued operations
|
(1,156 | ) | (76 | ) | (1,014 | ) | ||||||
|
Net income
|
$ | 2,596 | $ | 72,307 | $ | 2,567 | ||||||
|
Shares outstanding
:
|
||||||||||||
|
Weighted-average common shares outstanding
|
22,543 | 21,814 | 20,534 | |||||||||
|
Additional dilutive common stock equivalents
|
98 | 257 | 201 | |||||||||
|
Diluted shares outstanding
|
22,641 | 22,071 | 20,735 | |||||||||
|
Basic net income per share
:
|
||||||||||||
|
Basic net income per share from continuing operations
|
$ | 0.17 | $ | 3.32 | $ | 0.17 | ||||||
|
Basic net loss per share from discontinued operations
|
(0.05 | ) | (0.00 | ) | (0.05 | ) | ||||||
|
Basic net income per share
|
$ | 0.12 | $ | 3.32 | $ | 0.12 | ||||||
|
Diluted net income per share
:
|
||||||||||||
|
Diluted net income per share from continuing operations
|
$ | 0.16 | $ | 3.28 | $ | 0.17 | ||||||
|
Diluted net loss per share from discontinued operations
|
(0.05 | ) | (0.00 | ) | (0.05 | ) | ||||||
|
Diluted net income per share
|
$ | 0.11 | $ | 3.28 | $ | 0.12 | ||||||
| 54 |
|
2013 Quarters Ended
|
||||||||||||||||
|
March 31
|
June 30
|
September 30
|
December 31
|
|||||||||||||
|
Revenue
|
$ | 4,979 | $ | 4,427 | $ | 4,314 | $ | 5,637 | ||||||||
|
Operating income before patent
related income
|
2,202 | 543 | 1,039 | 754 | ||||||||||||
|
Income from patent arrangement
|
780 | - | - | - | ||||||||||||
|
Income from continuing operations
|
1,972 | 465 | 790 | 525 | ||||||||||||
|
Income (loss) from discontinued
operations
|
(115 | ) | (158 | ) | (1,943 | ) | 1,060 | |||||||||
|
Net income (loss)
|
1,857 | 307 | (1,153 | ) | 1,585 | |||||||||||
|
Net income (loss) per share – basic
|
$ | 0.08 | $ | 0.01 | ($ | 0.05 | ) | $ | 0.07 | |||||||
|
Net income (loss) per share – diluted
|
$ | 0.08 | $ | 0.01 | ($ | 0.05 | ) | $ | 0.07 | |||||||
|
2012 Quarters Ended
|
||||||||||||||||
|
March 31
|
June 30
|
September 30
|
December 31
|
|||||||||||||
|
Revenue
|
$ | 4,161 | $ | 3,514 | $ | 4,771 | $ | 4,858 | ||||||||
|
Operating income before patent
related income
|
1,120 | 390 | 1,767 | 1,766 | ||||||||||||
|
Gain on sale of patent assets
|
- | 71,226 | 15,167 | - | ||||||||||||
|
Income from patent arrangement
|
- | - | - | 1,121 | ||||||||||||
|
Income from continuing operations
|
1,167 | 54,938 | 10,272 | 6,006 | ||||||||||||
|
Income (loss) from discontinued
operations
|
(49 | ) | (12 | ) | 25 | (40 | ) | |||||||||
|
Net income
|
1,118 | 54,926 | 10,297 | 5,966 | ||||||||||||
|
Net income per share – basic
|
$ | 0.05 | $ | 2.52 | $ | 0.46 | $ | 0.27 | ||||||||
|
Net income per share – diluted
|
$ | 0.05 | $ | 2.49 | $ | 0.46 | $ | 0.26 | ||||||||
| 55 |
| 56 |
|
Col. A
|
Col. B
|
Col. C(1)
|
Col. C(2)
|
Col. D
|
Col. E
|
|||||||||||||||
|
Additions
|
||||||||||||||||||||
|
Balance at
|
Charged to
|
Charged
|
Deductions
|
Balance
|
||||||||||||||||
|
Beginning
|
Costs and
|
to Other
|
Charged to
|
at End
|
||||||||||||||||
|
of Period
|
Expenses
|
Accounts
|
Reserves
|
of Period
|
||||||||||||||||
|
Allowance for doubtful accounts receivable:
|
||||||||||||||||||||
|
2013
|
$ | 20 | $ | - | $ | - | $ | - | $ | 20 | ||||||||||
|
2012
|
$ | 30 | $ | - | $ | - | $ | 10 | $ | 20 | ||||||||||
|
2011
|
$ | 30 | $ | - | $ | - | $ | - | $ | 30 | ||||||||||
|
Inventory reserves:
|
||||||||||||||||||||
|
2013
|
$ | - | $ | - | $ | - | $ | - | $ | - | ||||||||||
|
2012
|
$ | 1,403 | $ | 126 | $ | - | $ | 1,529 | $ | - | ||||||||||
|
2011
|
$ | 989 | $ | 450 | $ | - | $ | 36 | $ | 1,403 | ||||||||||
|
Warranty reserves:
|
||||||||||||||||||||
|
2013
|
$ | 10 | $ | - | $ | - | $ | 10 | $ | - | ||||||||||
|
2012
|
$ | - | $ | 12 | $ | - | $ | 2 | $ | 10 | ||||||||||
|
2011
|
$ | - | $ | - | $ | - | $ | - | $ | - | ||||||||||
|
Deferred tax asset valuation allowance:
|
||||||||||||||||||||
|
2013
|
$ | - | $ | - | $ | - | $ | - | $ | - | ||||||||||
|
2012
|
$ | 40,476 | $ | - | $ | - | $ | 40,476 | $ | - | ||||||||||
|
2011
|
$ | 41,759 | $ | - | ($ | 1,283 | ) | $ | - | $ | 40,476 | |||||||||
| 57 |
| 58 |
| 59 |
|
Page
|
||
|
(1) Consolidated Balance Sheets as of December 31, 2013 and 2012
|
37
|
|
|
Consolidated Statements of Income and Comprehensive Income for each of the three
years in the period ended December 31, 2013
|
38
|
|
|
Consolidated Statements of Cash Flows for each of the
three years in the period ended December 31, 2013
|
39
|
|
|
Consolidated Statements of Stockholders’ Equity for each of
the three years in the period ended December 31, 2013
|
40
|
|
|
Notes to Consolidated Financial Statements
|
41
|
|
|
(2) Schedule II - Valuation and Qualifying Accounts
|
57
|
|
| (3) Exhibits: |
| The exhibits listed below are filed with or incorporated by reference in this report. | ||||
|
Exhibit No.
|
Description of Exhibit
|
|
||
|
2.1
†
|
Wireless Portfolio Patent Purchase Agreement, dated as of April 26, 2012, by and between Aware, Inc. and Intel Corporation (filed as Exhibit 2.1 to the Company’s Form10-Q/A for the quarter ended June 30, 2012 and incorporated herein by reference).
|
|||
|
2.2
|
DSL Patent Purchase Agreement, dated as of August 22, 2012, by and between Aware, Inc. and TQ Delta, LLC (filed as Exhibit 2.1 to the Company’s Form 8-K filed with the Securities and Exchange Commission on August 24, 2012 and incorporated herein by reference).
|
|||
|
3.1
|
Amended and Restated Articles of Organization, as amended (filed as Exhibit 3.1 to the Company’s Form 10-K for the year ended December 31, 2008 and incorporated herein by reference).
|
|||
|
3.2
|
Amended and Restated By-Laws (filed as Exhibit 3.1 to the Company’s Form 8-K filed with the Securities and Exchange Commission on December 10, 2007 and incorporated herein by reference).
|
|||
|
10.1*
|
1996 Stock Option Plan, as amended and restated (filed as Annex A to the Company’s Definitive Proxy Statement filed with the Securities and Exchange Commission on April 11, 2000 and incorporated herein by reference).
|
|||
|
10.2*
|
1996 Employee Stock Purchase Plan, as amended and restated (filed as Exhibit 99.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on November 29, 2005 and incorporated herein by reference).
|
|||
|
10.3*
|
Form of Indemnification Agreement for Directors and Officers of Aware, Inc. (filed as Exhibit 10.1 to the Company’s Form 8-K filed with the Securities and Exchange Commission on February 22, 2011 and incorporated herein by reference).
|
|||
|
10.4*
|
2001 Nonqualified Stock Plan (filed as Exhibit 99(d)(4) to the Company’s Schedule TO filed with the Securities and Exchange Commission on March 3, 2003 and incorporated herein by reference).
|
|||
| 10.5* |
Form of Nonqualified Stock Option Agreement under the 2001 Nonqualified Stock Plan for options granted to executive officers and directors prior to May 21, 2008 (filed as Exhibit 10.6 to Company’s Form 10-K for the year ended December 31, 2006 and incorporated herein by reference).
|
|||
|
10.6*
|
Form of Nonqualified Stock Option Agreement under the 2001 Nonqualified Stock Plan for options granted to executive officers and directors from and after May 21, 2008 (filed as Exhibit 10.8 to Company’s Form 8-K on May 22, 2008 and incorporated herein by reference)
|
|||
|
10.7*
|
Form of Unrestricted Stock Award for outside directors of Aware under the 2001 Nonqualified Stock Plan (filed as Exhibit 10.1 to Company’s Form 8-K filed with the Securities and Exchange Commission on July 28, 2010 and incorporated herein by reference).
|
|||
| 60 |
|
10.8*
|
Form of Unrestricted Stock Award for officers of Aware under the 2001 Nonqualified Stock Plan (filed as Exhibit 10.2 to Company’s Form 8-K filed with the Securities and Exchange Commission on July 28, 2010 and incorporated herein by reference).
|
||
|
10.9
|
Asset Purchase Agreement by and between Aware, Inc. and Lantiq Broadband Holdco, Inc. and Lantiq Deutschland GmbH dated October 14, 2009 (filed as Exhibit 10.8 to Company’s Form 10-K for the year ended December 31, 2009 and incorporated herein by reference).
|
||
|
10.12*
|
Form of Unrestricted Stock Award for executive officers and directors of Aware, Inc. under the 2001 Nonqualified Plan (filed as Exhibit 10.1 to the Company’s Form 8-K filed with the Securities and Exchange Commission on April 4, 2013 and incorporated herein by reference).
|
||
|
21.1
|
Subsidiaries of Registrant.
|
||
|
23.1
|
Consent of Independent Registered Public Accounting Firm.
|
||
|
23.2
|
Consent of Independent Registered Public Accounting Firm.
|
||
|
31.1
|
Certification of co-Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
||
|
31.2
|
Certification of co-Chief Executive Officer and Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
||
|
32.1
|
Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
||
|
101**
|
The following financial statements from Aware, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2013, formatted in XBRL (eXtensible Business Reporting Language), as follows: (i) Consolidated Balance Sheets as of December 31, 2013 and December 31, 2012; (ii) Consolidated Statements of Income and Comprehensive Income for the Years Ended December 31, 2013, December 31, 2012 and December 31, 2011; (iii) Consolidated Statements of Cash Flows for the Years Ended December 31, 2013, December 31, 2012 and December 31, 2011; (iv) Consolidated Statements of Stockholders’ Equity for the Years Ended December 31, 2013, December 31, 2012 and December 31, 2011; and (v) Notes to Consolidated Financial Statements.
|
| 61 |
| AWARE, INC. | |||
|
|
By:
|
/s/ Kevin T. Russell | |
| Kevin T. Russell | |||
| co-Chief Executive Officer & co-President | |||
| General Counsel | |||
|
|
By:
|
/s/ Richard P. Moberg | |
| Richard P. Moberg | |||
| co-Chief Executive Officer & co-President | |||
| Chief Financial Officer (Principal Financial and Accounting Officer) | |||
| Date: February 18, 2014 | |||
|
Signature
|
|
Title
|
|
|||
|
/s/ Kevin T. Russell
|
co-Chief Executive Officer, co-President,
|
|||||
|
Kevin T. Russell
|
General Counsel & Director
|
|||||
|
(co-Principal Executive Officer)
|
||||||
|
/s/ Richard P. Moberg
|
co-Chief Executive Officer, co-President,
|
|||||
|
Richard P. Moberg
|
Chief Financial Officer & Director
|
|||||
|
(co-Principal Executive Officer)
|
||||||
|
(Principal Financial and Accounting Officer)
|
||||||
|
/s/ John S. Stafford, Jr.
|
Chairman of the Board & Director
|
|||||
|
John S. Stafford, Jr.
|
||||||
|
/s/ John S. Stafford, III
|
Director
|
|||||
|
John S. Stafford, III
|
||||||
|
/s/ Adrian F. Kruse
|
Director
|
|||||
|
Adrian F. Kruse
|
||||||
|
/s/ Brian D. Connolly
|
Director
|
|||||
|
Brian D. Connolly
|
||||||
|
/s/ Brent P. Johnstone
|
Director
|
|||||
|
Brent P. Johnstone
|
||||||
| 62 |
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|